Sleep Duration and “on” Time during Different Periods of the Day and Night in Patients with Advanced Parkinson's Disease Receiving Adjunctive Ropinirole Prolonged Release
Figure 3
aAdjusted mean change from baseline in the amount of awake time spent “on” (hours) at week 24 LOCF (intent-to-treat population) (a) during the daytime (8 am–10 pm); (b) during each period of the daytime.
